Friday, April 9, 2021

Johnson Johnson set to begin India trial of its single-shot vaccine

Johnson Johnson set to begin India trial of its single-shot vaccine The U.S. drugs and healthcare giant has sent a letter to India#39;s Central Drugs Standard Control Organisation (CDSCO) saying it would "very shortly apply for permission to conduct clinical bridging trials in India," according to the report.

from Moneycontrol Business News https://ift.tt/3t5Hrg2

No comments:

Post a Comment

FII exodus deepens in 2026 at Rs 1.75 lakh crore as April outflows swell to Rs 43,967 crore; FOMC next trigger

Foreign institutional investors offloaded Indian equities worth Rs 17,140 crore last week, extending April's outflows to Rs 43,967 crore...